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The prevalence of tuberculosis is increasing worldwide. The
World Health Organization estimated that 8 million new cases
and 3 million deaths annually are directly attributable world-
wide to the disease each year, comprising 6% of all deaths [1].
Bloom and Murray [2] have identified categories of persons
that are at special risk within the general population, as well as
in the hospital setting [3,4]. Published data documenting the
current risk to health care workers (HCW) within the Carib-
bean region is scanty. In fact, lack of reliable data on yearly skin
testing of hospital employees have been shown to hamper the
evaluation of tuberculosis outbreaks in some centres [3,5]. In
the USA in 1993, health care workers accounted for 3.2% of
total cases of tuberculosis reported to the Centers for Disease
Control and Prevention [6]. Subsequent to this report, the
CDC issued guidelines designed to prevent spread of tubercu-
losis in health care facilities [7]. Persons latently infected with
Mycobacterium tuberculosis may be identified by skin testing with
purified protein derivatives (PPD) of the organism (e.g. Man-
toux test) and it is a reliable method for monitoring the exposure
of HCW to infected persons, and the best means for deter-
mining the efficacy of infection control efforts.
There was no employee tuberculosis surveillance screening
programme at the Eric Williams Medical Sciences Complex
(EWMSC) prior to this study. This study was therefore con-
ducted to define the prevalence of tuberculin reactivity among
health care providers at the EWMSC before the transfer of
patients and services from the National Chest Hospital at Caura
and to provide ongoing monitoring with the development of
specific infection control procedures.
The study was conducted from October 1, 1996 to January
31, 1997 and came about because the Ministry of Health was
contemplating transferring patients with tuberculosis and those
suspected of being infected with the organism, from the
National Chest Hospital (Caura Hospital) to the Eric Williams
Medical Sciences Complex (EWMSC), in April 1997. The
EWMSC is a 560-bed medical facility located in the north-
western part of Trinidad, and is one of four major government-
sponsored hospitals in Trinidad and Tobago. Trinidad is the
larger of the twin island republic (Trinidad and Tobago) with
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a population of about 1.25 million and located 11 km off the
northern coast of Venezuela in South America.
The Infection Control Committee of the EWMSC was con-
cerned about the status of the staff at the Complex and requested
that all health care providers be skin tested for tuberculosis. All
staff members in contact with patients were asked to report to
the newly established chest clinic which, along with the Infec-
tion Control Nurse, would assist in the skin testing program.
Data collected included age, gender, prior Mantoux test results
(measurement in mm) and history of previously diagnosed
tuberculosis or BCG vaccination. No attempt was made to
verify self-reported information by participants because no stan-
dardized employee health information existed during the study
period. Staff members who gave a history of previously non-
reactive Mantoux test (with or without a history of BCG) were
skin tested by the same method (Mantoux). A solution of
0.1 mL (5 TU) PPD (Tubersol; Connaught, Willowdale, ON,
Canada) was injected intradermally on the volar aspect of the
forearm and read at 72 h by one of two trained public health
nurses from the chest clinic. A positive Mantoux test was
defined as a reading 10 mm induration.
Participants with positive readings were offered free chest
radiographs and asked to submit three early morning sputum
specimens for culture. In most cases sputum samples were
received before chest radiographs were done and reported on.
Culture results were not available because shortly after the
screening process started, the National Public Health Lab-
oratory which processes sputa for tuberculosis began to experi-
ence internal structural problems that hampered laboratory
performance. Recommendations for prophylaxis and treatment
were offered according to guidelines from the World Health
Organization [1]. Data were analysed using Epi Info Software
version 6. Categorical variables were compared using chi-
squared or Fisher’s exact test. A P-value of 0.05 was con-
sidered significant, and all tests were two-tailed. Multivarate
analyses were performed by logistic regression.
From the 445 HCW at the EWMSC only 182 (40.9%)
responded to the request of the Infection Control Committee
for tuberculin (PPD) testing. Of these 182, 81 (44.5%) were
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PPD-positive. The PPD-positive rates were greatest (55%)
among the group aged at least 40 years, whereas the 25–29-
year-old age group had the lowest PPD-positive rates (19%).
The mean age for PPD-positive persons was slightly greater (44
years) than that for PPD-negative persons (38 years) (Table 1).
Among females, 46% were PPD positive versus a 38% positivity
rate for men. This was not statistically significant (x2 = 1.10;
P = NS). One hundred and seventy-five participants had no
history of BCG vaccination. Of these, 78 (44.6%) were PPD-
positive compared with three of seven (43%) with a positive
history of BCG vaccination.
Nurses comprised almost 60% of all PPD-positive persons
and were the greatest number screened (Table 2). None of the
PPD-positive staff members showed radiographic evidence of
Table 1 Characteristics of purified
protein derivatives (PPD) test-positive
and PPD test-negative health care
providers at the Eric Williams
Medical Sciences Complex in 1997
Significance
Characteristics Total PPD-positive PPD-negative x2; P-value
Number screened 182 81 101
Age group (years):
25 8 2 (25.0%) 6 12.23; 0.001
25–29 21 4 (19.0%) 17
30–34 29 12 (41.4%) 17
35–39 22 9 (40.9%) 13
40 97 53 (54.6%) 44
Age unknown 5 1 (20.0%) 4
Gender:
Male 40 15 (37.5%) 25 1.10; NS
Female 142 66 (46.5%) 76
BCG* vaccination history
Yes 7 3 (42.9%) 4
No 175 78 (44.6%) 97
* BCG, Bacillus of Calmette–Guerin.
Mean age for PPD-positivity and negativity rates were 44 and 38 years, respectively. Age range
(years) was 24–68 and 20–60 years for PPD-positive and PPD-negative participants, respectively.
Table 2 Distribution of purified
protein derivatives (PPD)
test results for 182 health care
providers according to job category
Total staff No. (%) of No. (%) of
Job category strength participating staff PPD-positive staff*
Registered nurse 170 99 (54.4) 48 (59.3)
Dental nurse 39 21 (11.5) 2 (2.5)
Physician 82 6 (3.3) 4 (5.0)
Dentist 14 1 (0.6) 1 (1.2)
Nursing assistant 35 12 (6.6) 7 (8.6)
Radiographer 16 6 (3.3) 2 (2.5)
Physiotherapist 11 2 (1.1) 1 (1.2)
Anaesthetic technician 5 1 (1.1) 1 (1.2)
Patient escort 53 17 (9.3) 7 (8.6)
CSPD techniciana 20 17 (9.3) 8 (8.6)
Total 445 182 81
* Based on participating workers.
a CSPD, central supplies processing department.
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pulmonary disease. Of the 82 doctors among the staff, only six
(7.3%) participated and only 7.1% of the 14 dentists was
involved in the screening process. The other category of PPD-
positive staff were dental nurses (two of 21), nursing assistants
(seven of 12), radiographers (two of six), patient escort (seven
of 17), physiotherapists (one of two) and central supplies pro-
cessing department personnel (seven of 17) (Table 2).
Multivarate regression analysis of PPD status, controlling for
age and gender demonstrated that increasing age and gender
were independently associated with a positive PPD skin test in
the study.
The prevalence of tuberculin reactivity in our survey was
45%. This closely agreed with observations made by Sepkowitz
et al. (New York, USA) [8], and Stracher et al. (USA) [9], who
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reported a positivity rate of 40% and 36%, respectively, but it
is considerable higher than rates described in past surveys. Fraser
et al. [10], found that 25% of physicians at Barnes Hospital in
St. Louis were infected with Mycobacterium tuberculosis, and other
reports from Cross and Hyams [11], The Center for Disease
Control and Prevention [12] and Bowden and McDiamid [13],
reported rates of 0.97, 4–5, and 25–48%, respectively. Our
comparison to these rates may seem inappropriate as the popu-
lations involved in these studies differed in a number of ways
from our study population. There are only scant references to
tuberculin positivity in HCW during workshops and seminars
in Trinidad, and no documentation for HCW in any other
Caribbean country with a similar economic and geographical
profile. In these studies however, higher rates of PPD-positivity
rates were associated with a past history of BCG vaccination
and the length of time participants were employed. But the
high prevalence rate that were observed in this study could not
be due to prior BCG vaccination alone, because 44.6% (78 of
175) of HCW with a positive PPD skin test, had no history of
BCG vaccination. BCG vaccination was discontinued in 1976
because of low prevalence rates, 5 per 100 000 population
(records of National Chest Hospital, Caura). In view of the on-
going AIDS epidemic with an apparent increase in tuberculosis
cases (135 per 100 000, in 1996 to 210 per 100 000 population
in 1997 (up to June) [14], the decision has been taken by the
authorities to re-introduce BCG vaccination at birth and in
school children. At present no decision has been taken to offer
BCG vaccination to HCW.
The 45% of our HCW with tuberculin skin conversion may
be reflecting a relatively high base line rate of community-
acquired Mycobacterium tuberculosis infection as suspected cases
of tuberculosis are admitted directly to the National Chest
Hospital, not to the EWMSC. This may also have serious
implications for nosocomial infections and infection control
policies for the institution. In Trinidad and Tobago in the
1940s, the prevalence of tuberculosis was 100 per 100 000
population, whereas in the 1970s the rate was 5 per 100 000
population. However, in the 1980s the rate was double (10
per 100 000) that of the 1970s, and in 1996 and 1997 (up to
June), the rates were 35 per 100 000 population and 210 per
100 000 population, respectively. These incidence rates parallel
the increase in AIDS cases. Between 1993 to the first quarter
of 1997, the rates per 100 000 population were 20.5, 22.6, 27.0
and 9.3 (1st quarter 1997) [15], respectively. These figures
reflect a cross-sectional survey of the population, but no specific
data were made available for the HCW at the nation’s health
care facilities. Although HIV infection is associated with an
increased prevalence of pulmonary tuberculosis cases [16], it is
not known within this society how much the epidemiology
of Mycobacterium tuberculosis infection, as opposed to disease,
overlaps with the epidemiology of HIV infection. It is therefore
difficult to predict the impact of the local HIV-infection/
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AIDS situation on the increase in prevalence of tuberculosis
cases.
In conclusion, a high rate of tuberculin reactivity was
detected among HCW at the EWMSC, prior to the transfer of
patients and services from the National Chest Hospital at Caura.
This high prevalence rate may reflect already high undetected
rates of infection in the community as alluded to in the report
by Beach et al. [14]. Reducing the risk of exposure will depend,
not on screening via PPD testing per se, but on implementation
of effective infection control procedures, for example: res-
piratory isolation for patients presenting with fever and cough;
protection of immunocompromised (e.g. HIV-infected) pat-
ients from exposure to suspected or proven TB cases; chemo-
prophylaxis for individuals exposed to known cases of TB and
BCG vaccination of HCW. Full evaluation of all suspected
cases and therapy are essential. All PPD tuberculin skin-test
positive HCW, were offered isoniazid prophylaxis, but com-
pliance was difficult to assess and subsequent follow-up was not
possible as most PPD positive participants in our study have left
the employ of the EWMSC.
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Haemophilus influenzae can cause a variety of invasive diseases
in children. These infections are responsible for sequelae [1]
and important mortality [2–4]. Resistance of H. influenzae to a
variety of antimicrobial agents has been reported with increasing
frequency in recent years [5,6], although in countries where
vaccination against H. influenzae serotype b has been intro-
duced, an important decline in the incidence of invasive disease
has been noticed [7,8].
Recommendations for vaccination policies and antibiotic
treatment must be guided by local epidemiology. Recent data
on invasive infections of H. influenzae in Africa are very rare.
The aim of this study was to determinate the serotype, biotype
and the levels of antibiotic resistance of H. influenzae respon-
sible for invasive disease at the Casablanca IbnRochd University
hospital over a period of 2.5 years.
From June 1994 to December 1996, 117 strains of H.
influenzae were isolated from children aged 0–15 years with
invasive disease, who were admitted to the Ibn Rochd Uni-
versity Hospital of Casablanca. Among the 117 strains, 109
were serotyped, 112 were biotyped, 115 were tested for beta-
lactamase production and 85 were tested for their susceptibilities
to cefotaxime, chloramphenicol, erythromycin and rifampin.
Serotyping was carried out by testing the supernatant of a
broth culture in tryptic soy broth supplemented with Fields
Enrichment (BBL) by countercurrent-immuno-electrophoresis
with polyvalent and monovalent antisera (Difco Laboratories,
Detroit, MI, USA). Biotype was determined by the study of
ornithine decarboxylase and indole production and urea util-
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ization with the API 10 s system (BioMerieux, Narcy L’etoile,
France) or Rosco tablets and urea indole medium (Sanofi-
Pasteur, Marnes La Coquette, France). Beta-lactamase pro-
duction was detected with a nitrocefin-impregnated disc (Carr
Scarborough Microbiologicals, Decatur, Georgia, USA). Qual-
ity control for betalactamase production was carried out with
Staphylococcus aureus ATCC 29213. The minimum inhibitory
concentrations were determined on Mueller–Hinton chocolate
agar by the agar dilution method with an inoculum of 104 CFU
per spot. The breakpoints used were those recommended by
the National Committee for Clinical Laboratory Standards [9].
H. influenzae ATCC 49247 was used as quality control. Data
entry and analysis were carried out using Epi Info 5 (WHO).
From the 117 isolates of H. influenzae responsible for invasive
disease, 74.4% were recovered from cerebrospinal fluid. The
other sites were blood (16.2%), articular fluid (6.8%) and res-
piratory tract specimens (2.6%). These infections were caused
mainly by serotype b (99.1%). The nontypable isolates were
rare in our series; only one case was isolated from articular fluid.
The age of the patients was available for 113 children and 89.3%
occurred in children that were less than 2 years of age (Figure
1). In our series, all biotypes could be responsible for invasive
diseases in children, but at a different magnitudes: biotype I
(57.1%), II (13.4%), VII (9.8%), VI (5.3%), VIII (5.4%), IV
(3.6%), III (4.5%) and V (0.9%). Three isolates (2.6%) produced
a beta-lactamase. These strains belonged to serotype b, and
were responsible for meningitis. One of these strains was also
resistant to chloramphenicol, although chloramphenicol was
